Buscar
Mostrando ítems 1-10 de 129
Novel Soluplus®-TPGS mixed micelles for encapsulation of paclitaxel with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines
(Elsevier Science, 2016-04)
The aim of this work was to develop mixed micelles based on two biocompatible copolymers of polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol (Soluplus®) and D-α-tocopheryl polyethylene-glycol 1000 succinate ...
Role of glutathione-S-transferase and codon 72 of P53 genotypes in epithelial ovarian cancer patients
(SpringerNew YorkEUA, 2006)
Hoxa10 Controls Proliferation, Migration And Invasion In Oral Squamous Cell Carcinoma
(E-CENTURY PUBLISHING CORPMADISON, 2015)
Mixed micelles for encapsulation of doxorubicin with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines versus Doxil®
(Elsevier France-editions Scientifiques Medicales Elsevier, 2017-11)
Doxorubicin (DOX) is used as a “first-line” antineoplastic drug in ovarian and metastatic breast cancer. However, serious side effects, such as cardiotoxicity have been reported after DOX intravenous administration. Hence, ...
Lactadherin: From a Well-Known Breast Tumor Marker to a Possible Player in Extracellular Vesicle-Mediated Cancer Progression
(2022)
Lactadherin is a secreted glycoprotein associated with the milk fat globule membrane, which is highly present in the blood and in the mammary tissue of lactating women. Several biological functions have been associated ...
Biomarkers of sensitivity to potent and selective antitumor 2-(4-Amino-3-methylphenyl)-5-fluorobenzothiazole (5F203) in ovarian cancer
(Wiley, 2013-10)
2-(4-Amino-3-methylphenyl)-5-fluorobenzothiazole (5F203, NSC 703786) lysylamide belongs to a novel mechanistic class of antitumor agents. It elicits activity against ovarian, breast, kidney and colorectal cancer models. ...